The Defense Department's Partnership With a Third Party Lab to Assess Generic Drug Quality

The Department of Defense is reportedly partnering with an independent third party lab to assess the quality and safety of its generic medications. This potential move comes amid growing concerns over ongoing shortages of drugs in the United States. According to the FDA, a majority of drug shortages stem from quality control issues. If this pilot is successful, it could serve as a model for other large agencies to verify generic drug quality.